Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.35 |
| ▸ | KDM6B | O15054 | 1/20 | 0.35 |
| ▸ | KDM5C | P41229 | 1/20 | 0.35 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.35 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.30 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL297784 | 0.84 | EGLN1 (0.41) | ALDH1A1TSHREGLN1KDM6BKDM5C | |
| SCHEMBL523077 | 0.81 | AKR1B1 (0.41) | ALDH1A1TSHREGLN1KDM6BKDM5C | |
| SCHEMBL4249812 | 0.79 | DGKA (0.46) | ALDH1A1TSHR | |
| SCHEMBL719196 | 0.78 | AKR1B1 (0.43) | ALDH1A1TSHR | |
| Succinic Acid SCHEMBL4803598 | 0.78 | ALDH1A1 (0.54) | ALDH1A1TSHREGLN1KDM6BKDM5C | |
| SCHEMBL297783 | 0.76 | TSHR (0.36) | ALDH1A1TSHRLMNA | |
| Succinic Acid SCHEMBL1234712 | 0.75 | ALDH1A1 (0.52) | ALDH1A1TSHREGLN1KDM6BKDM5C | |
| SCHEMBL10613663 | 0.75 | AKR1B1 (0.45) | ALDH1A1TSHR | |
| SCHEMBL2306714 | 0.74 | ALDH1A1 (0.54) | ALDH1A1TSHREGLN1KDM6BKDM5C | |
| SCHEMBL522534 | 0.74 | TSHR (0.44) | ALDH1A1TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255058-B2 | Complex alcohol ester composition, method for production same, and use of same | FUJIFILM CORPORATION (JP) | 2016-02-09 | — | — | US | disclosed |
| US-20120184474-A1 | COMPLEX ALCOHOL ESTER COMPOSITION, METHOD FOR PRODUCTION SAME, AND USE OF SAME | FUJIFILM CORPORATION (JP) | 2012-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120184474-A1 | COMPLEX ALCOHOL ESTER COMPOSITION, METHOD FOR PRODUCTION SAME, AND USE OF SAME | ADH1C, ADH1A, ASH2L | ALDH1A1 922/4885TSHR 4276/4885EGLN1 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.